Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-12-000364)

Filing Details

Accession Number:: 0001209191-12-000364
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2012-01-03 16:07:01
Reporting Period:: 2011-12-28

Filing Date:: 2012-01-03
Accepted Time:: 2012-01-03 16:07:01
Original Submission Date:: 2011-12-30
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1292519	Invivo Therapeutics Holdings Corp.	NVIV	Surgical & Medical Instruments & Apparatus (3841)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1503383	Francis Reynolds	C/O Invivo Therapeutics Holdings Corp. One Broadway, 14Th Floor Cambridge MA 02142	Ceo, Cfo	Yes	Yes	Yes	No

Transaction Summary

Sold:	95,000 shares	Avg. Price: $2.52	Total Value: $239,020.00
Number of Shares After Transactions:	14,909,160 shares

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.00001 Par Value	Disposition	2011-12-29	95,000	$2.52	14,909,160	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

This amendment is filed to correct the Transaction Date in column 2, line 2, of the original Form 4 filed on December 30, 2011.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.45 to $2.60, inclusive.